Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Overview of attention for article published in Lancet Oncology, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 3 public wall posts from 3 users.

Extraskeletal myxoid chondrosarcoma is a rare sarcoma with low sensitivity to cytotoxic chemotherapy. Retrospective evidence…

#PublicaSalutIB Ús del pazopanib pel tractament de tumors fibrosos solitaris típics https://buff.ly/3aU6yJS Son Espases …

This technical abstract discusses use of pazopanib to treat extraskeletal myxoid #chondrosarcoma. #sarcomaresearch #sarcomatrea…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.